Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-miniCHOP in Elderly DLBCL
NCT01087424Phase 2Completed
- Sponsor
- Lymphoma Study Association
- Start
- Apr 2006
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
A Phase 2 trial of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone in diffuse large B-cell lymphoma (DLBCL), sponsored by Lymphoma Study Association. Started Apr 2006; status: completed.
02
Drugs
rituximabcyclophosphamidedoxorubicinvincristineprednisone
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01087424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087424.